Early Sirolimus Therapy in Renal Transplant Recipients at High Risk: Is It Justified? Article

Halim, MA, Al-Otaibi, T, Johny, KV et al. (2009). Early Sirolimus Therapy in Renal Transplant Recipients at High Risk: Is It Justified? . TRANSPLANTATION PROCEEDINGS, 41(7), 2784-2788. 10.1016/j.transproceed.2009.07.015

cited authors

  • Halim, MA; Al-Otaibi, T; Johny, KV; Hamid, MH; Al-Waheeb, S; Hasaneen, H; Awadain, WH; Nawas, KM; El-Sayed, A; Said, T; Nair, MP; Nampoory, MRN

sustainable development goals

authors

publication date

  • September 1, 2009

webpage

published in

keywords

  • CALCINEURIN INHIBITORS
  • CYCLOSPORINE
  • FAILURE
  • Immunology
  • Life Sciences & Biomedicine
  • OUTCOMES
  • RANDOMIZED-TRIAL
  • REGIMEN
  • Science & Technology
  • Surgery
  • TACROLIMUS
  • Transplantation

Location

  • Shiraz, IRAN

Digital Object Identifier (DOI)

publisher

  • ELSEVIER SCIENCE INC

start page

  • 2784

end page

  • 2788

volume

  • 41

issue

  • 7